Treatment of Hepatitis C

Rejekine. Is Hepatitis be treated?
Can, chronic hepatitis C can be treated with Pegylated Interferon and Ribavirin.

Treatment of Hepatitis C as early as possible is very important. Although your body has to fight against infection, but only 15% were successful, the treatment is still needed to prevent chronic hepatitis C and helps reduce the possibility of a broken heart.

Sometimes, the treatment of hepatitis C requires a long time, and can not be helped. But because the disease can become severe over time, it is important to seek proper treatment from your doctor.

Diagnosis and early treatment is very urgent and important. A significant percentage of people who do it can recover from Hepatitis C and showed improvement of his heart.

The goal of treatment of hepatitis C is to eliminate the virus from your body as early as possible to prevent the worsening developments and end-stage liver disease.

Most forms of interferon alpha could only last one day but can be modified through PEGylation process to make it last longer. Although interferon alfa can be used as a single hepatitis C drugs including pegylated interferon, the study showed more effective when combined with anti-viral ribavirin.

Three compounds used in the treatment of Hepatitis C are:

Interferon alpha
Is a protein made naturally by the human body to enhance the immune system / immunity and regulate other cell functions. Drugs recommended for chronic hepatitis C is of inteferon alpha can be in the form of natural or synthetic.

Pegylated interferon alfa
Created by combining water-soluble molecules called "polyethylene glycol (PEG)" with the alpha interferon molecule. Modification of alpha interferon is no longer in the body, and studies have shown more effective in making the last response to the virus from chronic hepatitis C patients compared to regular interferon alfa.

Ribavirin
Is anti-viral drugs are used together with interferon alfa for chronic hepatitis C treatment. Ribavirin alone is not effective when used against hepatitis C virus, but with the combination of interferon alpha, is more effective than alpha inteferon own.
This treatment has been accepted based on its ability to generate a response against the virus in patients with chronic hepatitis C disease.

The patient is said to have a response against the virus if the number of Hepatitis C virus is so low that it was not detected in standard tests Hepatitis C virus RNA and if those levels remained undetectable for more than 6 months after treatment is completed.